Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)

PHASE4TerminatedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Depressive Disorder
Interventions
DRUG

paroxetine 10mg tablet

1 or 2 tablet(s) once a day

DRUG

paroxetine 20mg tablet

1 tablet once a day

DRUG

matched placebo to paroxetine 10mg

2 tablets once a day

DRUG

matched placebo to paroxetine 20mg

1 tablet once a day

Trial Locations (33)

445-0064

GSK Investigational Site, Aichi

453-0015

GSK Investigational Site, Aichi

474-8710

GSK Investigational Site, Aichi

479-0837

GSK Investigational Site, Aichi

910-1193

GSK Investigational Site, Fukui

800-0207

GSK Investigational Site, Fukuoka

802-0064

GSK Investigational Site, Fukuoka

810-0001

GSK Investigational Site, Fukuoka

836-0004

GSK Investigational Site, Fukuoka

002-8029

GSK Investigational Site, Hokkaido

653-0841

GSK Investigational Site, Hyōgo

661-0002

GSK Investigational Site, Hyōgo

673-8501

GSK Investigational Site, Hyōgo

921-8163

GSK Investigational Site, Ishikawa

765-8501

GSK Investigational Site, Kagawa

210-0006

GSK Investigational Site, Kanagawa

220-0004

GSK Investigational Site, Kanagawa

244-0816

GSK Investigational Site, Kanagawa

860-8556

GSK Investigational Site, Kumamoto

861-8002

GSK Investigational Site, Kumamoto

862-0920

GSK Investigational Site, Kumamoto

390-8510

GSK Investigational Site, Nagano

631-0036

GSK Investigational Site, Nara

634-8522

GSK Investigational Site, Nara

710-0057

GSK Investigational Site, Okayama

534-0021

GSK Investigational Site, Osaka

545-8586

GSK Investigational Site, Osaka

560-0082

GSK Investigational Site, Osaka

596-0076

GSK Investigational Site, Osaka

410-2295

GSK Investigational Site, Shizuoka

770-8076

GSK Investigational Site, Tokushima

107-0052

GSK Investigational Site, Tokyo

107-0062

GSK Investigational Site, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00812812 - Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study) | Biotech Hunter | Biotech Hunter